Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

ELMD US Equity

Electromed, Inc.Health Care · Electromedical & Electrotherapeutic Apparatus · CIK 1488917 · FY ends Jun 30
$40.87
-0.55 (-1.33%)
USD · as of 2026-08-19 · marketstack

Legal & controls

5 of 5 annual reports readable here

Item 3 and Item 9A as filed · every verdict is the registrant’s own sentence, printed below it · a filing that fails an extraction gate reads “not extracted”

Fiscal yearFiledItem 3ICFRdisclosure controlsmaterial weaknessFiling
2025-06-302025-08-26described hereeffectiveeffectivenone in Item 9AEDGAR

Item 3 · Occasionally, we may be party to legal actions, proceedings, or claims in the ordinary course of business, including claims based on the assertions of patent and trademark infringement. Corresponding costs are accrued when it is probable that loss will be incurred, and the amount can be precisely or reasonably estimated. We are not aware of any undisclosed actual or threatened litigation that would have a material adverse effect on our financial condition or results of operations.

Item 9A · ICFR · Based on this assessment, management has concluded that, as of June 30, 2025, our internal control over financial reporting was effective.

Item 9A · disclosure controls · Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective.

2024-06-302024-08-27in the noteseffectiveeffectivenone in Item 9AEDGAR

Item 3 · The disclosure regarding legal proceedings set forth in Note 11 to our Financial Statements in Part II, Item 8 of this Annual Report on Form 10-K is incorporated herein by reference. Occasionally, we may be party to legal actions, proceedings, or claims in the ordinary course of business, including claims based on the assertions of patent and trademark infringement. Corresponding costs are accrued when it is probable that loss will be incurred, and the amount can be precisely or reasonably estimated. We are not aware of any undisclosed actual or threatened litigation that would have a material adverse effect on our financial condition or results of operations.

Item 9A · ICFR · Based on this assessment, management has concluded that, as of June 30, 2024, our internal control over financial reporting was effective.

Item 9A · disclosure controls · Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective.

2023-06-302023-08-22in the noteseffectiveeffectivenone in Item 9AEDGAR

Item 3 · The disclosure regarding legal proceedings set forth in Note 11 to our Financial Statements in Part II, Item 8 of this Annual Report on Form 10-K is incorporated herein by reference. Occasionally, we may be party to legal actions, proceedings, or claims in the ordinary course of business, including claims based on the assertions of patent and trademark infringement. Corresponding costs are accrued when it is probable that loss will be incurred, and the amount can be precisely or reasonably estimated. We are not aware of any undisclosed actual or threatened litigation that would have a material adverse effect on our financial condition or results of operations.

Item 9A · ICFR · Based on this assessment, management has concluded that, as of June 30, 2023, our internal control over financial reporting was effective.

Item 9A · disclosure controls · Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective.

2022-06-302022-08-23in the noteseffectiveeffectivenone in Item 9AEDGAR

Item 3 · The disclosure regarding legal proceedings set forth in Note 11 to our Financial Statements in Part II, Item 8 of this Annual Report on Form 10-K is incorporated herein by reference. Occasionally, we may be party to legal actions, proceedings, or claims in the ordinary course of business, including claims based on the assertions of patent and trademark infringement. Corresponding costs are accrued when it is probable that loss will be incurred, and the amount can be precisely or reasonably estimated. We are not aware of any undisclosed actual or threatened litigation that would have a material adverse effect on our financial condition or results of operations.

Item 9A · ICFR · Based on this assessment, management has concluded that, as of June 30, 2022, our internal control over financial reporting was effective.

Item 9A · disclosure controls · Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective.

2021-06-302021-08-24as filedeffectiveeffectivenone in Item 9AEDGAR

Item 3 · We may be party to legal actions, proceedings, or claims in the ordinary course of business. We are not aware of any actual or threatened litigation that would have a material adverse effect on our financial condition or results of operations.

Item 9A · ICFR · Based on this assessment, management has concluded that, as of June 30, 2021, our internal control over financial reporting was effective.

Item 9A · disclosure controls · Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective.

5 of 5 annual reports on record have their filing text cached on this host; the rest are listed with their EDGAR link and no extraction, because this surface never fetches from SEC on a page load.

  • Item 3 and Item 9A are located in the filing HTML already cached on this host and read with the same line-anchored item matcher and largest-gap body disambiguation the filing-narrative pass uses for Item 1A and Item 7 — no fetch, no model, no summarization.
  • A heading is accepted as a section only when it is not a table-of-contents row (a trailing page number), not a quoted reference in prose, and names its own section; the span must then clear a per-item length band and carry readable text after the heading. Anything that fails a gate is served as 'not extracted' with the reason — never as a default value.
  • An effectiveness conclusion is read only from a sentence that names its own control set (disclosure controls and procedures, or internal control over financial reporting) and states an outcome. Conditional sentences — the standard limitations paragraph and forward-looking remediation language — are excluded, because they are hypotheses rather than conclusions.
  • When a filing's own sentences disagree — an effective conclusion beside an unremediated material-weakness disclosure, or two conclusions of opposite sign — no verdict is asserted. A wrong 'controls were effective' reading is worse than no reading.
  • Every verdict is shown beside the verbatim sentence it was read from. The excerpt is the filing's own words, capped at 1,200 characters; the filing itself is one link away.